Iquix FDA Approval History
FDA Approved: Yes (Discontinued) (First approved March 1, 2004)
Brand name: Iquix
Generic name: levofloxacin ophthalmic
Dosage form: Ophthalmic Solution
Company: Santen
Treatment for: Corneal Ulcer
Marketing Status: Discontinued
Iquix (levofloxacin) is a topical fluoroquinolone indicated for the treatment of bacterial corneal ulcers.
Development timeline for Iquix
| Date | Article |
|---|---|
| Mar 1, 2004 | Approval Iquix Santen - Treatment for Bacterial Corneal Ulcers |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
